Skip to content

Comparison of lavender and Rosa Damascena scents on anxiety and vital signs of patients under coronary artery Angiography

Comparison of lavender and Rosa Damascena scents on anxiety and vital signs of patients under coronary artery Angiography

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017011325732N11
Enrollment
48
Registered
2017-02-15
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety. Anxiety disorder, unspecified

Interventions

Intervention 1: The first intervention (aromatherapy with essential oils of lavender): Intervention for aromatherapy with lavender oil (with a concentration of 100% herbal medicines provided by compan
Prevention
Behavior
Third intervention (placebo): From 22 to 6 am on angiography in patients and at a rate of three drops of water in a small glass container will be placed at a distance of 1 m from the patient.
The first intervention (aromatherapy with essential oils of lavender): Intervention for aromatherapy with lavender oil (with a concentration of 100% herbal medicines provided by companies Barij Essenc
The second intervention (aromatherapy with essential oils of damask rose): intervention for aromatherapy with essential oils of damask rose (with a concentration of 100% herbal medicines provided by c
Fourth intervention (control): patients only receive routine care without any additional intervention.

Sponsors

Semnan University of Medical Sciences, Deputy of Research and Technology.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 35-70 years, alert, a healthy sense of smell; no drugs, anti-anxiety and depression in the past year, the non-occurrence of a traumatic event over a month before the intervention; angiography for the first time. Exclusion criteria: the history of asthma, bronchitis, chronic respiratory diseases, sensitivity to smell fragrant essential oils, drug addiction, mental disorders, angiography for acute myocardial infarction, hemodynamic disorder.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Before intervention (before 22 hours) and immediately after the intervention (after 6 pm). Method of measurement: Spielberger Anxiety Inventory.

Secondary

MeasureTime frame
Blood pressure. Timepoint: Before intervention (before 22 hours) and immediately after the intervention (after 6 pm). Method of measurement: Scorpions pressure Riester (Germany).;Heart beat. Timepoint: Before intervention (before 22 hours) and immediately after the intervention (after 6 pm). Method of measurement: Touch the right wrist radial pulse.;Respiratory rate. Timepoint: Before intervention (before 22 hours) and immediately after the intervention (after 6 pm). Method of measurement: See the chest.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Asgari

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026